Guobin Wang
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Immunology top 2%
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Oncology 37
- Cancer Immunotherapy and Biomarkers 9
- Colorectal Cancer Surgical Treatments 9
- Cancer-related Molecular Pathways 7
- Immunology 21
- T-cell and B-cell Immunology 9
- Co-authors
- Kaixiong Tao (66 shared papers)Weiping Zou (9 shared papers)Ke Wu (18 shared papers)Ende Zhao (12 shared papers)Kaixiong Tao (11 shared papers)Ilona Kryczek (7 shared papers)Shuang Wei (6 shared papers)Xiaoming Lu (12 shared papers)
- Journals
- Oncotarget (7 papers)Medicine (7 papers)PLoS ONE (4 papers)Obesity Surgery (4 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Guobin Wang
149 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 112
- Oncology 1.4k
- Immunology 1k
- Cancer Research 586
- Hepatology 277
- Gastroenterology 100
Countries citing papers authored by Guobin Wang
This map shows the geographic impact of Guobin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Wang more than expected).
Fields of papers citing papers by Guobin Wang
This network shows the impact of papers produced by Guobin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Wang. The network helps show where Guobin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guobin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 431 | |
| 2 | 2018 | 378 | |
| 3 | 2015 | 357 | |
| 4 | 2015 | 237 | |
| 5 | 2011 | 233 | |
| 6 | 2009 | 153 | |
| 7 | 2011 | 151 | |
| 8 | 2010 | 100 | |
| 9 | 2017 | 95 | |
| 10 | 2010 | 85 | |
| 11 | 2014 | 81 | |
| 12 | 2008 | 77 | |
| 13 | 2014 | 76 | |
| 14 | 2018 | 71 | |
| 15 | 2016 | 63 | |
| 16 | 2021 | 63 | |
| 17 | 2014 | 60 | |
| 18 | 2016 | 55 | |
| 19 | 2013 | 51 | |
| 20 | 2017 | 50 |
About Guobin Wang
Guobin Wang is a scholar working on Oncology, Immunology, Cancer Research, Surgery and Molecular Biology, having authored 155 papers that have together received 4.6k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), T-cell and B-cell Immunology (9 papers), Colorectal Cancer Surgical Treatments (9 papers), Bariatric Surgery and Outcomes (8 papers), Gastrointestinal Tumor Research and Treatment (7 papers), RNA Interference and Gene Delivery (7 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (1k citations), Cancer Research (586 citations), Hepatology (277 citations) and Gastroenterology (100 citations). Guobin Wang has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Kaixiong Tao, Weiping Zou, Ke Wu, Ende Zhao, Kaixiong Tao, Ilona Kryczek, Shuang Wei, Xiaoming Lu, Liang Shi and Xiaoming Shuai. Their work appears in journals such as Oncotarget, Medicine, PLoS ONE, Obesity Surgery and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.